Likewise, chemerin and adipsin decreased after an oral lipid challenge in a putative anti-inflammatory adipokine response aiming to counteract the proinflammatory effects of postprandial hyperlipidemia [84]. The gene discussed is CFD; the disease is hyperlipidemia.